REFRACTORY NEUROBLASTOMA
Clinical trials for REFRACTORY NEUROBLASTOMA explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY NEUROBLASTOMA trials appear
Sign up with your email to follow new studies for REFRACTORY NEUROBLASTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for kids with tough neuroblastoma: combo therapy tested
Disease control Not yet recruitingThis study is for children and young adults (ages 1 to 30) with neuroblastoma that has returned, not responded, or worsened after prior treatment. It tests adding a drug called iberdomide to standard chemoimmunotherapy to see if it is safe and works better. The goal is to control…
Matched conditions: REFRACTORY NEUROBLASTOMA
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 06:48 UTC
-
Double immune attack: new cell combo targets tough childhood cancers
Disease control Not yet recruitingThis early-phase study tests a new treatment for children and young adults with osteosarcoma or neuroblastoma that has returned or not responded to standard therapy. The treatment combines two types of genetically modified immune cells: NK cells designed to fight the tumor enviro…
Matched conditions: REFRACTORY NEUROBLASTOMA
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated May 26, 2026 06:43 UTC